Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Επικοινωνία Submitted by Δημήτρης Σπάχος on Πέμ, 04/30/2015 - 11:26
